Benign Prostatic Hyperplasia Causes
Benign Prostatic Hyperplasia Causes
Benign prostatic hyperplasia is not a disease a man catches or earns; it is the predictable behaviour of a gland that has been programmed to grow under androgens. Two things must be true for it to develop: the man must be old enough, and his prostate must be exposed to androgens. Neither is a matter of behaviour. The enlargement begins in the inner part of the gland, around the urethra, and it grows because the balance of cell proliferation and cell death inside the prostate shifts with age. Against that background, three further factors are associated with having a larger prostate or with more troublesome symptoms — body weight and metabolic health, chronic inflammation within the gland, and family history — and these are the parts of the story a man can influence, although modestly. What follows from all of this is the fact most patients actually came for: benign prostatic hyperplasia is not prostate cancer. It does not turn into cancer, it does not raise the risk of cancer, and the two conditions arise in different parts of the gland. They simply share an age group, which is why the assessment looks for both rather than assuming the benign explanation because it is the common one.
Androgens: the reason the gland grows at all
The dependence of the prostate on male hormones is the oldest established fact in this disease, and it explains several things a patient will notice during treatment:
- The basic mechanism — testosterone enters the prostate cells and is converted there by the enzyme 5-alpha reductase into dihydrotestosterone, a more potent androgen. It is this locally produced hormone that drives the proliferation of prostate cells.
- What follows from it — men whose androgen production is removed very early in life do not develop the condition, and blocking the conversion with medication reduces gland volume over months. The disease is hormonal in its origin, not inflammatory or infectious.
- The misunderstanding to correct — BPH is not caused by having too much testosterone. Most men with an enlarged prostate have entirely normal hormone levels; what has changed is how the gland responds to them, and how the balance between cell growth and cell death has shifted with age.
- What this means practically — no diet, supplement or lifestyle change removes the hormonal drive. This is why treatment focuses on the consequences of growth — relaxation, shrinking, or removing the obstructing tissue — rather than on trying to prevent the growth itself.
Age, and the family a man comes from
Age is the strongest single factor, and it acts on everyone:
- The pattern with age — microscopic evidence of hyperplasia can be found in a substantial proportion of men from their forties onwards, and both the size of the gland and the likelihood of symptoms increase steadily with each decade. It is one of the most common conditions in adult men, which is worth remembering when it feels like a personal failing.
- Family history — a man whose father or brother has had an enlarged prostate, or prostate surgery, is at higher risk, and tends to develop the problem earlier. The pattern is strong enough that it belongs in the history-taking.
- Why it matters practically — a family history does not change the treatment options, but it does inform when to start looking, and it is a reason for a man in his forties with symptoms to be assessed rather than reassured by his age.
Body weight, blood sugar and the metabolic picture
The link between the metabolic syndrome and prostate enlargement is consistent enough to be worth knowing, even though it is not the whole explanation:
- What is observed — men with obesity, type 2 diabetes and the metabolic syndrome tend to have larger prostates and more troublesome urinary symptoms than men of the same age without those conditions.
- How it may work — insulin resistance, altered sex-hormone balance, a sympathetic nervous system that runs more tensely, and low-grade inflammation are all plausible mediators, and more than one is probably involved.
- The honest size of the effect — this is an association rather than a cause, and losing weight will not make an enlarged prostate shrink. It does, however, improve the general picture in which symptoms are experienced, and it is worth doing for reasons that extend well beyond the urinary tract.
Inflammation: the process that runs alongside
Chronic inflammation is present in a large share of prostate tissue removed for benign enlargement, and it is more than a bystander:
- What is found — inflammatory cells are commonly seen in hyperplastic prostate tissue, and men with evidence of prostate inflammation tend to report more symptoms for the same degree of obstruction.
- What it may explain — some of the irritative symptoms, particularly urgency and frequency, may reflect inflammation rather than the mechanical obstruction alone, which is part of why treating only the blockage does not always relieve every symptom.
- What it does not mean — inflammation in the prostate is not an infection that a course of antibiotics will cure, and it is not a precursor to cancer. It is a chronic process that contributes to symptoms and is managed as part of the whole picture, not as a separate disease to be eradicated.
Not cancer, not a precursor — but the same age group
This is the section most patients are actually looking for, so it deserves to be unambiguous:
- Different tissue, different place — benign hyperplasia arises in the transition zone, the inner part of the gland wrapped around the urethra, and it is made of glandular and muscular tissue that is not malignant. Prostate cancer usually begins in the peripheral zone, the outer part of the gland, where it grows silently because it does not obstruct the urethra early.
- No progression from one to the other — BPH does not become prostate cancer, and having BPH does not raise the risk of developing prostate cancer. They are two common conditions of the same organ in the same age group, and that overlap is the whole of their relationship.
- Why the cancer tests still happen — because the two coexist so often. A man with an enlarged prostate can also have prostate cancer, and the enlargement would explain nothing about it. The PSA test and the rectal examination are how that second question is answered rather than assumed away — and worth noting, both a large gland and a tumour can raise PSA.
- What surgery does and does not remove — an operation for BPH removes the obstructing inner tissue. It is not a cancer operation, and it does not remove the outer part of the gland where cancer usually starts, which is why surveillance for cancer continues on its own schedule afterwards.
Who is most likely to progress
Not everyone with an enlarged prostate deteriorates. The factors that predict progression are worth knowing, because they are the ones measured at follow-up:
- Age and symptom severity — older men and those with higher symptom scores are more likely to worsen over time.
- Prostate size and PSA — a larger gland, and a higher PSA for the same gland size, are both associated with a greater chance of progression and of complications developing.
- Residual urine — a significant post-void residual identifies a bladder that is beginning to decompensate and is one of the strongest reasons to stop watching and start treating.
- Kidney function — a rising creatinine indicates that the obstruction has already had consequences, and it moves the decision firmly towards relief.
- What to do with this — these are the things reassessment measures. A patient being watched is not being left alone; he is being followed against specific numbers, and that is the difference between a plan and an omission.